Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
saiseiiryo.jp “再生医療ポータル” was launched by The Japanese Society for Regenerative Medicine in March 2019. Its goal is to provide patients and the general public with professional yet easy-to-understand information about regenerative medicine. It is not a typical SaaS or enterprise software product; it is closer to a public-interest medical information portal.
The site’s main sections include basic explanations of regenerative medicine, related news, a provider search tool, clinical trial information, introductions to social implementation projects, an FAQ, and downloadable materials for patients. The provider search supports queries by treatment name, disease name, and other criteria. Its data is organized based on the Ministry of Health, Labour and Welfare’s public “届出された再生医療等提供機関の一覧” list. The site also provides 《あなたが受けたい再生医療のためのしおり》 and checklists to help patients make informed decisions before receiving treatment or participating in research.
The main content does not show any subscription plans, packages, enterprise editions, or trial mechanisms, and the site’s content appears to be freely accessible. Up to 20 printed copies of the booklet can be provided free of charge, but applicants must cover shipping costs. From an enterprise software perspective, the site does not disclose third-party system integrations, team collaboration features, permission management, APIs, SDKs, or developer documentation. It also does not provide details on cloud deployment or self-hosting options.
In its terms of use, the site states that the inquiry form collects information such as email address, name, affiliation, address, and phone number, and that this information is used for contact and confirmation purposes. It is not provided to third parties except in response to legal requests or with the user’s consent. The provider database also includes a clear disclaimer: search results do not mean the society endorses the effectiveness or safety of any treatment, nor do they constitute a recommendation to seek care.
The strengths are its clear positioning and strong public-interest nature. The content emphasizes that regenerative medicine is still exploratory in many areas and reminds users to make cautious judgments. The FAQ and booklets are practical for patients. Downsides include the possibility that information may be outdated and should be reconfirmed with medical institutions; the patient consultation desk is currently suspended; and the Japanese-language content is not user-friendly for Chinese users. It is suitable for the general public, patients, and research-related users who want to understand Japan’s regenerative medicine policies, institutions, and basic knowledge.
Access from mainland China is not covered in the source text, so its status is unknown. From a payments perspective, there are almost no online purchase scenarios. Alternative information sources include PMDA, the Ministry of Health, Labour and Welfare, AMED, and public pages from university hospitals. Chinese users should prioritize information published by the National Health Commission, the National Medical Products Administration, and reputable hospitals.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on saiseiiryo.jp official site.
saiseiiryo.jp is an Japan Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach saiseiiryo.jp directly.